Oligodendroglioma: Advances in Molecular Mechanisms and Immunotherapeutic Strategies

Oligodendroglioma is a central nervous system tumor defined by <i>IDH1/2</i> mutations and 1p/19q co-deletion. Current management involves maximal resection followed by radiotherapy/chemotherapy, yielding a 20-year survival rate of 37% for grade 3 tumors according to the WHO 2021 classif...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Yongxin Zhao, Yan Yu, Weizhi Chen, Xiaojun Zhang, Jing Lv, Heping Zhao
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	oligodendroglioma tumor microenvironment immunotherapy oncolytic virus therapy CAR T-cell therapy immune checkpoint blockade therapy
Online Access:	https://www.mdpi.com/2227-9059/13/5/1133

Similar Items

Current development in adenoviral vectors for cancer immunotherapy
by: Greyson Willis Grossman Biegert, et al.
Published: (2021-12-01)

Current and future immunotherapeutic approaches in pancreatic cancer treatment
by: Pooya Farhangnia, et al.
Published: (2024-06-01)

Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular therapies
by: Zhiwei Han, et al.
Published: (2025-03-01)

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
by: Hang Liang, et al.
Published: (2024-06-01)

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance
by: Marta Barisa, et al.
Published: (2024-04-01)

Advances in Cellular Immune Theranostic Approaches for Glioblastoma: Current Trends and Future Directions
by: Ying Gong, et al.
Published: (2025-08-01)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
by: Jing Jin, et al.
Published: (2020-05-01)

Immune-based cancer therapies: mechanistic insights, clinical progress, and future directions
by: Mahalakshmi Devaraji, et al.
Published: (2025-09-01)

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
by: Luyao Wang, et al.
Published: (2022-01-01)

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
by: Daniel E. Meyers, et al.
Published: (2017-06-01)

Tumor–Immune Interactions in Pediatric Oral Rhabdomyosarcoma: A Narrative Review on Immuno-Oncology and Emerging Therapies
by: Omar A. El Meligy, et al.
Published: (2025-09-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
by: Jagmohan Singh, et al.
Published: (2021-11-01)

Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
by: Benjamin Koh, et al.
Published: (2023-12-01)

Targeted therapy and immunotherapy for malignant mesothelioma
Published: (2024-10-01)

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
by: So Young Yoo, et al.
Published: (2020-06-01)

Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors
by: LIANG Yingyun, CHEN Jianhua
Published: (2024-07-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
by: Akseli Hemminki
Published: (2012-08-01)

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
by: Tingting Wang, et al.
Published: (2022-10-01)

CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy
by: Jan Beck, et al.
Published: (2018-12-01)

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
by: Peer Andre Berger, et al.
Published: (2022-11-01)

CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
by: Jan David Beck, et al.
Published: (2020-04-01)

An update on the clinical trial research of immunotherapy for glioblastoma
by: Yichen Zhou, et al.
Published: (2025-05-01)

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
by: Yasunari Matsuzaka, et al.
Published: (2025-04-01)

Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
by: Artur Katz, et al.
Published: (2009-03-01)

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
by: Qianqian Xue, et al.
Published: (2023-04-01)

Cancer immunotherapies: advances and bottlenecks
by: Rui Rui, et al.
Published: (2023-08-01)

Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy
by: Minmin Wang, et al.
Published: (2024-08-01)

Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
by: Mingyong Zha, et al.
Published: (2025-05-01)

CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy
by: Lena M. Kranz, et al.
Published: (2017-10-01)

Harnessing viral power: immunotherapy's synergy with targeted oncolytic viruses
by: Mohammad Shenagari, et al.
Published: (2023-12-01)

Current Trends in Cancer Immunotherapy
by: Ivan Y. Filin, et al.
Published: (2020-12-01)

Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option
by: Jiasen He, et al.
Published: (2023-01-01)

Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review
by: Jiamin Xu, et al.
Published: (2024-07-01)

Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01)

CAR-T cell therapy in china: innovations, challenges, and strategic pathways
by: Lihui Yan, et al.
Published: (2025-08-01)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
by: Yichi Zhang, et al.
Published: (2022-01-01)

Enhanced cellular therapy: revolutionizing adoptive cellular therapy
by: Meng-Yao Xu, et al.
Published: (2024-04-01)

Current and prospective strategies in the management of Glioblastoma
by: Hanna Wołodkiewicz, et al.
Published: (2025-06-01)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
by: Zhongbing Qi, et al.
Published: (2022-09-01)